Scientific Reviews
Product Guides
Blogs
Topics
Targeted therapy! The Capetin Prize winning "Click Chemistry" can be used like this!Targeted therapy! The Nobel Prize winning "Click Chemistry" can be used like this!2025-02-06
28 Results for "
PAC1
" in MedChemExpress (MCE) Product Catalog:
Products (28)
28 Results for "PAC1" in MCE Product Catalog:
7
5
5 Cited Publications
Cat. No.: HY-P0221
CAS No.: 137061-48-4
Synonyms: Pituitary Adenylate Cyclase Activating Polypeptide 38
Research Areas:
3
Target:
Research Areas:
3
Target:
Research Areas:
2
2 Cited Publications
Target:
Research Areas:
PA-8 is a potent, selective and orally active PACAP type I (PAC1) receptor antagonist. PA-8 inhibits the phosphorylation of CREB induced by PACAP in PAC1-, but not VPAC1- or VPAC2-receptor. PA-8 also inhibits PACAP-induced cAMP elevation with an IC50 of 2 nM [1] .
1
1 Cited Publications
Synonyms: PAC1R antagonist 1
Target:
Research Areas:
PA-915 (PAC1R antagonist 1) is a potent and orally active antagonist of PAC1 receptor. PA-915 inhibits pituitary adenylate cyclase-activating polypeptide (PACAP)-induced CREB phosphorylation. PA-915 can inhibit PACAP- and nerve injury-induced allodynia. PA-915 can be used for the research of neuropathic pain [1].
Cat. No.: HY-P99509
CAS No.: 2225850-33-7
Synonyms: AMG-301
Target:
Research Areas:
Cat. No.: HY-P0221C
CAS No.: 129405-61-4
Target:
Research Areas:
Cat. No.: HY-P1845
CAS No.: 138764-85-9
Target:
Research Areas:
Target:
Research Areas:
PA-9 is a pituitary adenylate cyclase-activating polypeptide (PACAP) type I (PAC1) receptor antagonist. PA-9 dose dependently inhibits PACAP-induced cAMP elevation with an IC50 of 5.6 nM. PA-9 can be used for the research of neuropathic and/or inflammatory pain [1].
Cat. No.: HY-P3483
CAS No.: 135374-80-0
Research Areas:
Cat. No.: HY-13523S
CAS No.: 1287241-26-2
Synonyms: Procaspase activating compound 1-d8
Cat. No.: HY-P1845A
Target:
Research Areas:
Cat. No.: HY-159632
Research Areas:
PAR4 antagonist 6 (Compound 12) is a PAR4 antagonist, with IC50 values of 134 and 401 nM for hPAR4 (PAC1) and mPAR4 (PAC1), respectively [1].
Cat. No.: HY-119158
CAS No.: 1476847-58-1
Research Areas:
VU0652925, an analog of BMS986120, is a PAR4 antagonist, with IC50 values of 43 pM and 39.2 pM for PAC1 and P-selectin, respectively. VU0652925 is able to suppress GPIIbIIIa activation [1].
Cat. No.: HY-P0221A
Synonyms: Pituitary Adenylate Cyclase Activating Polypeptide 38 TFA
Research Areas:
Cat. No.: HY-P1817
CAS No.: 144025-82-1
Target:
Research Areas:
Cat. No.: HY-RS04060
Target:
Research Areas:
DUSP2 Human Pre-designed siRNA Set A contains three designed siRNAs for DUSP2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.
Cat. No.: HY-P3483A
Research Areas:
Cat. No.: HY-RS11336
Target:
Research Areas:
PSMG1 Human Pre-designed siRNA Set A contains three designed siRNAs for PSMG1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.
- 1
- 2
-
-
Protocols
Targeted therapy! The Capetin Prize winning "Click Chemistry" can be used like this!Targeted therapy! The Nobel Prize winning "Click Chemistry" can be used like this!A suitable model is crucial in drug screening experiments. Organs can mimic the three-dimensional functional structure of internal organs, have similar spatial organization to corresponding organs, maintain some key characteristics, and reproduce some physiological functions. They are widely used for modeling and personalized drug screening physiological functions.2025-02-06
